SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

VEERHEALTH CARE

BSE: 511523 29 Sep 2025
Healthcare
₹ 18.17
Veerhealth Care Limited specializes in Pharmaceuticals within the Healthcare sector.

VEERHEALTH CARE - Share Price & Details

Market Cap
₹35.7
High /Low
24.3 / 9.29
Stock P/E
70.1
Book Value
₹11.1
Dividend Yield
0.0
ROCE
3.14
ROE
₹1.77
Face Value
10.0
PEG Ratio
0.73
EVEBITDA
₹20.2
Debt
4.91
CMP / FCF
-11.0
Debt to equity
₹0.22
NP Ann
0.39
High price all time
30.1
Piotroski score
₹2.0
Graham Number
7.98
No. Eq. Shares
2.0
Net CF
₹0.92
Net profit
0.51
Price to book value
1.61
Interest Coverage
₹2.67
Low price all time
0.9
Industry PE
33.0
Reserves
₹2.22
Free Cash Flow
₹-9.20

Broker Recommendations

No broker recommendations available

We couldn’t find any recent recommendations for this company (matched by symbol or BSE code). Please check back later.


Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
FABINO ENTERPRISES LIMITEDNANANANA5.0984.8
Triochem Products Ltd.,NANANANA0
VEERHEALTH CARE LIMITEDNANANANA35.770.1
SAMSRITA LABS LIMITEDNANANANA34
Chandra Bhagat Pharma LimitedNANANANA32.445.7

Peer Comparison Chart


About VEERHEALTH CARE

Veerhealth Care Limited, with Security Code 511523, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.


Order Book


Latest News

Is Veerhealth Care Limited a Smart Pick for Retirement Portfolios - Sector Performance Review & 5 Stocks Every Investor Should Own

(27 Sep 2025)
【Market Insights】✌️ Find winning stocks fast with free real-time market data and analysis.
Read more →

Veerhealth Care Limited Receives Fresh Orders from its US Customer

(18 Sep 2025)
Veerhealth Care Limited announced it has received fresh orders from its US customer 2 No x 40 FT FCL for Drug OTC range of products.
Read more →

Veerhealth Care Faces Mixed Signals Amid Declining Stock Performance and Debt Concerns

(16 Sep 2025)
Veerhealth Care, a microcap in the Pharmaceuticals & Biotechnology sector, has recently seen a change in its evaluation due to shifting...
Read more →

Briefs: Mankind Pharma, Mangalam Drugs and Organics and Veerhealth Care

(26 Aug 2025)
Crisil ESG Ratings & Analytics assigns ESG 57 rating to Mankind Pharma. Crisil ESG Ratings & Analytics Limited, a SEBI registered ESG Rating...
Read more →

Briefs: Mankind Pharma, Mangalam Drugs and Organics, Veerhealth Care and Shelter Pharma

(25 Aug 2025)
Crisil ESG Ratings & Analytics assigns ESG 57 rating to Mankind Pharma. Crisil ESG Ratings & Analytics Limited, a SEBI registered ESG Rating...
Read more →

Veerhealth Care received further repeat Export Order from existing USA customer

(23 Aug 2025)
Veerhealth Care Limited, Ayuveer, backed by Veerhealth Care's expertise in Ayurveda, specializes in crafting ayurvedic medicines and oral...
Read more →